Under Development
(Compounds are not offered for sale in the countries where they are protected by patents)
Sr No |
Active Pharmaceutical Ingredients ( Grades ) |
CAS No |
New Product Offering (Developed at R&D Scale) |
||
1 |
Bictegravir Na (IH) |
1611493-60-7 |
2 |
Aripiprazole |
129722-12-9 |
3 |
Risperidone |
106266-06-2 |
4 |
Olanzapine |
132539-06-1 |
5 |
Etodolac |
41340-25-4 |
Pipeline APIs ( Under Development ) |
||
1 |
Tafenoquine Succinate (IH) |
106635-80-7 |
2 |
Pretomanid (IH) |
187235-37-6 |
Future APIs |
||
1 |
Ganaplacide (IH) |
1261113-96-5 |
| Pipeline APIs (Under Development) | |
| Ganaplacide (IH) | 1261113-96-5 |
| Tafenoquine Succinate (IH) | 106635-80-7 |
| Pretomanid (IH) | 187235-37-6 |
| Under Development | |
| List of Products | Therapeutic Category |
| Tafenoquine Succinate | Anti malarial activity |
| Bictegravir Na | Anti retroviral activity |
| Favipiravir | Anti viral activity and used to treat COVID-19 |
| Molnupiravir | Anti viral activity |
| Future APIs | |
| Risedronate Na | 115436-72-1 |
| Etodolac | 41340-25-4 |
| Future APIs | |
| List of Products | Therapeutic Category |
| Elvitegravir | Anti retroviral activity |
| Cobicistat | Anti retroviral activity |
| Daclatasvir dihydrochloride | Anti retroviral for hepatitis C |
| Ledipasvir | Anti retroviral for hepatitis C |
| Velpatasvir | Anti retroviral for hepatitis C |
